US 12,215,081 B2
Pharmaceutical intermediate
Adam Haluszczuk, Gdansk (PL); and Dorota Pogoda, Syrynia (PL)
Assigned to ZAKLADY FARMACEUTYCZNE POLPHARMA S.A., Starogard Gdanski (PL)
Appl. No. 17/609,034
Filed by ZAKLADY FARMACEUTYCZNE POLPHARMA S.A., Starogard Gdanski (PL)
PCT Filed May 20, 2020, PCT No. PCT/EP2020/064126
§ 371(c)(1), (2) Date Nov. 5, 2021,
PCT Pub. No. WO2020/234383, PCT Pub. Date Nov. 26, 2020.
Claims priority of application No. 19460027 (EP), filed on May 22, 2019.
Prior Publication US 2022/0213037 A1, Jul. 7, 2022
Int. Cl. C07D 211/58 (2006.01)
CPC C07D 211/58 (2013.01) 8 Claims
OG exemplary drawing
 
1. 4-(4-Fluorobenzylamino)-1-methylpiperidine trihydrate.